HIBADH
protein-coding3-hydroxyisobutyrate dehydrogenase
Gene summary
This gene encodes a mitochondrial 3-hydroxyisobutyrate dehydrogenase enzyme. The encoded protein plays a critical role in the catabolism of L-valine by catalyzing the oxidation of 3-hydroxyisobutyrate to methylmalonate semialdehyde. [provided by RefSeq, Nov 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~137.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009371
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009371
Submitter: ClinGen
*HIBADH* was first reported in relation to autosomal recessive 3-Hydroxyisobutyrate dehydrogenase deficiency and 3-hydroxyisobutyric aciduria in 2021 by Meyer et al., PMID:34176136. At least three unique variants (missense and frameshift) have been reported in humans. Evidence supporting this gene-disease relationship includes both case-level data and experimental data. Variants in this gene have been reported in at least 3 probands in 2 publications (PMIDs:34176136, 35174513). Patient symptoms ranged from delayed psychomotor and speech development to apparently asymptomatic. No supporting segregation information is available. The disease mechanism appears to be biallelic loss-of-function, with a deficiency in HIBADH leading to an increase in 3-hydroxyisobutyric acid, a metabolite produced from the multi-step catabolism of Valine and potentially the phenotypes seen in conjunction with the biochemical abnormality. This gene-disease relationship is supported by the biochemical function of 3-Hydroxyisobutyrate dehydrogenase, an enzyme responsible for the conversion of 3-hydroxyisobutyrate to methylmalonate semialdehyde. Biallelic variants in *ALDH6A1* encoding for methylmalonate semialdehyde dehydrogenase (MMSDH) are also associated with 3-hydroxyisobutyric aciduria, with patients presenting with phenotypes ranging from severe developmental delay to virtually asymptomatic (Limited Classification 10/14/2022). In summary, there is limited evidence to support this gene-disease relationship. In affected individuals, a low valine diet may improve phenotypes such as developmental delay, however there is insufficient evidence at this time to determine if the clinicla phenotypes observed in these patients are related to the 3-Hydroxyisobutyrate dehydrogenase deficiency. Although more evidence, genetic and experimental, is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. A classification of limited was approved by the ClinGen Aminoacidopathy GCEP on 3/24/2023 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0000688
Submitter: Ambry Genetics
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HIBADH variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_152740.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | ||||
| missense | 43 | 2 | 45 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 0 | 0 | 52 | 2 | 0 | 54 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_689953.1 | 8 | MANE Select | |
| Ensembl | ENSP00000265395.2 | 8 | MANE Select | |
| RefSeq | NP_001417678.1 | 6 | Standard | |
| Ensembl | ENSP00000390205.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Valine, leucine and isoleucine degradation - Homo sapiens (human)
- 3-Methylglutaconic Aciduria Type I
- Valine, Leucine and Isoleucine Degradation
- 2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency
- Isovaleric Aciduria
Biological Process
- valine catabolic process
- branched-chain amino acid catabolic process
- oxidation-reduction process
Molecular Function
- 3-hydroxyisobutyrate dehydrogenase activity
- oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
- NADP binding
- NAD binding
Cellular Component
- mitochondrion
- mitochondrial matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000265395
- Coding exons
- 8
- Length
- 137554
- Individuals with no LoFs
- 125729
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 17
- Defined
- 125746
- p
- 0.0000676
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.131 | 167 | 172 | 0.972 | 0.00000833 | 2156 |
| Missense (PolyPhen) | 46 | 65.601 | 0.70121 | 779 | ||
| Synonymous | -0.499 | 67 | 62.0 | 1.08 | 0.00000321 | 681 |
| Loss of Function | 2.02 | 6 | 14.2 | 0.422 | 6.94e-7 | 195 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000054 | 0.000053 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.290
Intolerance Scores
- LoFtool
- 0.572
- RVIS EVS
- -0.43
- RVIS percentile EVS
- 25.15
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.997
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |